Overview
The Narcotic Drugs Amendment (Fees) Regulations 2026 is a federal instrument that amends fee provisions in the Narcotic Drugs Regulation 2016. That regulation sits under the Narcotic Drugs Act 1967. The instrument is administered by the Department of Health, Disability and Ageing.
Commencement and repeal
The instrument commenced on 17 June 2026 and was repealed on 7 September 2026, meaning it was in force for less than three months.
What the instrument changes
The instrument amends the fee provisions in the Narcotic Drugs Regulation 2016. The source does not specify which fee amounts were changed or which licence or permit categories were affected.
Key actions
- Check the full text of the instrument at https://www.legislation.gov.au/F2026L00751 if your business holds a licence under the Narcotic Drugs Act 1967 - for example, a medicinal cannabis or other controlled substance licence - to confirm whether any fees applicable to you changed during the period 17 June 2026 to 7 September 2026.
- Contact the Department of Health, Disability and Ageing if clarification is needed on whether updated fees applied to a particular licence category during that period. The source does not provide a direct contact number or email.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.